相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
Claudia Ollauri-Ibanez et al.
ANGIOGENESIS (2020)
Curcumin stimulates angiogenesis through VEGF and expression of HLA-G in first-trimester human placental trophoblasts
Sanjay Basak et al.
CELL BIOLOGY INTERNATIONAL (2020)
Therapeutic effect of TRC105 and decitabine combination in AML xenografts
June Baik et al.
HELIYON (2020)
Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling
Xiaoling Zhang et al.
CANCER BIOLOGY & MEDICINE (2020)
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma
Toni K. Choueiri et al.
ONCOLOGIST (2019)
Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways
Lin Chen-Yuan et al.
PHYTOMEDICINE (2019)
An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
C. R. Mehta et al.
ANNALS OF ONCOLOGY (2019)
Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells
Chiao-Yun Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer
Wan Nur Baitty Wan Mohd Tajuddin et al.
NUTRIENTS (2019)
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105
Yingmiao Liu et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells
Alessia Brossa et al.
Oncotarget (2018)
Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties
Mahdi Hatamipour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer
Ying-Yi Chen et al.
MOLECULES (2018)
Bevacizumab Alone or in Combination With TRC105 for Patients With Refractory Metastatic Renal Cell Cancer
Tanya B. Dorff et al.
CANCER (2017)
Phase I and Preliminary Phase II Study ofTRC105in Combination with Sorafenib in Hepatocellular Carcinoma
Austin G. Duffy et al.
CLINICAL CANCER RESEARCH (2017)
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma
Andrea B. Apolo et al.
CLINICAL GENITOURINARY CANCER (2017)
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
M. Paauwe et al.
ONCOGENE (2016)
Demethoxycurcumin Modulates Human P-Glycoprotein Function via Uncompetitive Inhibition of ATPase Hydrolysis Activity
Yu-Ning Teng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
Molecular Pathways: Can Activin-like Kinase Pathway Inhibition Enhance the Limited Efficacy of VEGF Inhibitors?
Rupal S. Bhatt et al.
CLINICAL CANCER RESEARCH (2014)
An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer
Michael S. Gordon et al.
CLINICAL CANCER RESEARCH (2014)
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
Yingmiao Liu et al.
INVESTIGATIONAL NEW DRUGS (2014)
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
Yingmiao Liu et al.
CANCER MEDICINE (2014)
Endoglin for tumor imaging and targeted cancer therapy
Madelon Paauwe et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: An in vitro and in vivo study
Ming-Jyh Sheu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to impede endothelial cell proliferation
Christopher C. Pan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Toxicarioside A Inhibits Tumor Growth and Angiogenesis: Involvement of TGF-β/Endoglin Signaling
Feng-ying Huang et al.
PLOS ONE (2012)
Modulation of TGF-β signaling by endoglin in murine hemangioblast development and primitive hematopoiesis
Liying Zhang et al.
BLOOD (2011)
ALK1 as an emerging target for antiangiogenic therapy of cancer
Sara I. Cunha et al.
BLOOD (2011)
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
Reason Wilken et al.
MOLECULAR CANCER (2011)
Transforming growth factor-beta and endoglin signaling orchestrate wound healing
Manoj Valluru et al.
FRONTIERS IN PHYSIOLOGY (2011)
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
Ester Fonsatti et al.
CARDIOVASCULAR RESEARCH (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF)
Song-Shei Lin et al.
CANCER LETTERS (2009)
Endoglin (CD105): A marker of tumor vasculature and potential target for therapy
Nikolaos A. Dallas et al.
CLINICAL CANCER RESEARCH (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
TGF-β receptor function in the endothelium
F Lebrin et al.
CARDIOVASCULAR RESEARCH (2005)
Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma
M Zangari et al.
CLINICAL CANCER RESEARCH (2004)
Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: Crucial involvement of the down-regulation of matrix metalloproteinase
JH Kim et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Endoglin:: An accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies
E Fonsatti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Signaling of transforming growth factor-β family members through Smad proteins
S Itoh et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Endoglin, an ancillary TGF beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
HM Arthur et al.
DEVELOPMENTAL BIOLOGY (2000)
分享论文
